Found: 6
Select item for more details and to access through your institution.
FMP30 is required for the maintenance of a normal cardiolipin level and mitochondrial morphology in the absence of mitochondrial phosphatidylethanolamine synthesis.
- Published in:
- Molecular Microbiology, 2011, v. 80, n. 1, p. 248, doi. 10.1111/j.1365-2958.2011.07569.x
- By:
- Publication type:
- Article
Inefficient Transcription of the Myelin Basic Protein Gene Possibly Causes Hypomyelination in Myelin-Deficient Mutant Mice.
- Published in:
- Journal of Neurochemistry, 1987, v. 48, n. 2, p. 470, doi. 10.1111/j.1471-4159.1987.tb04116.x
- By:
- Publication type:
- Article
Characterization of the anti?platelet actions of FK419, a novel non?peptide antagonist of platelet GPIIb/IIIa.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 233, doi. 10.1002/ddr.10382
- By:
- Publication type:
- Article
FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2005, v. 25, n. 1, p. 75, doi. 10.1038/sj.jcbfm.9600009
- By:
- Publication type:
- Article
FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2005, v. 25, n. 1, p. 108, doi. 10.1038/sj.jcbfm.9600013
- By:
- Publication type:
- Article
A Combined Treatment With Tacrolimus (FK506) and Recombinant Tissue Plasminogen Activator for Thrombotic Focal Cerebral Ischemia in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2002, v. 22, n. 10, p. 1205, doi. 10.1097/01.wcb.0000037993.34930.72
- By:
- Publication type:
- Article